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NSAIDs and Their Interactions with Bacterial Growth
Abstract:
Non-steroidal anti-inflammatory drugs (NSAIDs) are common medications that are
frequently used to suppress symptoms of viral and bacterial infections. The increase in concern
of antibiotic resistance has led researchers to study the effects of NSAIDs on bacterial growth or
on common antibiotics. This study aims to determine whether commonly used NSAIDs,
ibuprofen and acetaminophen, have any antibacterial properties that might help suppress
bacterial growth. In conjunction, this study also looks to see whether the combination of NSAIDs
and an antibiotic can further reduce bacterial growth than if an antibiotic is used alone. Our
procedure consisted of lab-grown Escherichia coli (E. coli) that was mixed with ibuprofen
(8ug/ml), acetaminophen (15ug/ml), or ampicillin at either 8 or 15ug/ml. These concentrations
are based on typical blood serum levels of each respective drug. UV spectrophotometer was used
to determine bacterial growth through absorbance values (600nm). The results show larger
absorbance values (meaning greater bacterial growth) when ibuprofen and acetaminophen are
present. Data also shows that when NSAIDs are used in combination with ampicillin, absorbance
values would be greater than if ampicillin was used alone. Possible mechanisms leading to these
results could include horizontal gene transfer in E. coli or inhibiting the antibiotic effects of
ampicillin. Future research should focus on determining the primary mechanism NSAIDs use to
promote bacterial growth or inhibit antibiotics.
Introduction:
The aim of this study is to determine whether common non-steroidal anti-inflammatory
drugs (NSAIDs) contain any antibacterial properties that can complement the effects of
antibiotics. With increasing prevalence of antibiotic resistance, understanding the relationship
between NSAIDs and antibiotics is fundamental to the treatment of bacterial infections. Many
types of NSAIDs are used to alleviate a wide range of symptoms, especially those present with
bacterial infections. It is common that antibiotics and NSAIDs are used in combination with each
other, making it more important to understand potential synergistic effects. Another relevant
application is the increasing demand for drug repurposing. Manufacturing new drugs is a timely
and costly process, so if already existing drugs can be considered pleiotropic (have one or more
mechanisms), it would aid in treatment of diseases. According to Jelena Obad et al., suitability
tests are required by pharmaceutical companies to ensure that drugs directly affect the targeted
chemical, physical, and biological characteristic (2015). Many non-antibiotic drugs will initially
show antimicrobial activity, but the pharmaceutical industry makes efforts to neutralize these
attributes in order to maintain the intended purpose (Obad et al., 2015).
The relationship between antibiotics and NSAIDs has been extensively researched.
However, there are still areas in this field of study that require further research. The mechanisms
used by bacteria to acquire antibiotic resistant properties are poorly understood, especially when
NSAIDs are used as an additional component to alleviate symptoms of bacterial infections.
According to Alli Abdul Hussein and AL-Janabi, they found that ibuprofen and acetaminophen
showed antibacterial activity in multiple strains of bacteria (2010). To determine the effects of

NSAIDs on bacterial growth, they used tubes of Mueller Hinton broth containing various
concentrations of ibuprofen and acetaminophen. Their results displayed inhibited bacterial
growth as the concentration of both NSAIDs increased. This study directly relates to
understanding our experiment, because the authors analyzed the growth of bacteria in relation to
NSAID exposure. On the contrary, other researchers found that NSAIDs may contribute to an
increase in antibiotic resistance. According to Taru Verma et al., common NSAIDs may induce
phenotypic antibiotic resistance in Escherichia coli (2018). The bacterial gene marA is a
transcription factor that leads to the increased activity of efflux pumps that help remove
antibiotics out of bacteria cells. The authors of this study determined that ibuprofen,
acetaminophen, and acetylsalicylic acid (ASA) upregulates the marA gene in the bacteria E. coli.
Another study determined whether ibuprofen or the antibiotic pivmecillinam is more
effective at treating E. coli infections. According to Ingvild Vik et al., the antibiotic
pivmecillinam was more effective at treating the E. coli infection; however, ibuprofen still
displayed positive effects towards the resolution of the infection (2018). They concluded that
ibuprofen alone should not be a primary treatment for bacterial infections, but the combination of
antibiotics and NSAIDs could provide beneficial results. Bacteria biofilm has also been a topic
of interest when determining how some bacteria strains become resistant to antibiotics. Gramnegative bacteria, like E. coli, produce a biofilm coating that wraps around the bacteria cell wall
and acts as a protective mechanism to ensure bacteria survivability. A study conducted by
Cláudia Leão et al., suggested that NSAIDs inhibit biofilm formation through disrupted DNA
synthesis that codes for replication and membrane repair of the biofilm (2020). This disruption
would allow more antimicrobial agents to enter the bacteria cells, promoting greater
effectiveness of antibiotics.
The present study investigates whether ibuprofen or acetaminophen have any
antibacterial properties. Additionally, this study would like to see whether the combination of
ibuprofen or acetaminophen with ampicillin will lead to greater reduction in bacteria growth. To
measure bacterial growth, absorbance values will be recorded using a spectrophotometer at
600nm. It is hypothesized that absorbance values will lower when NSAIDs are present with E.
coli. Additionally, it is predicted that absorbance values will be even lower when the NSAIDs
are combined with the antibiotic ampicillin.
Methods/Materials:
The bacteria used in this experiment was Escherichia coli (E. Coli). The E. coli was
provided by the microbiology lab at Saint John’s University. E. Coli is a gram-negative bacteria
found in the intestines of humans and animals. The E. coli strain obtained for this experiment
was lab grown, having the benefit of limited antibiotic resistant properties. The NSAIDs used in
this experiment were ibuprofen and acetaminophen. Stock solutions of these NSAIDs were
prepared by crushing an over-the-counter 200mg oral tablet of ibuprofen and a 500mg oral tablet
of Tylenol (acetaminophen) using a mortar and pestle. Once crushed to powder, it was dissolved
in equal parts of 95% ethanol and 1N hydrochloric acid (HCl), 50mL each. HCl was used to
resemble the gastrointestinal environment that the NSAID tablets would be exposed to if
ingested. Ethanol was used as a solvent due to its ability to dissolve NSAID tablets. A similar
study conducted by James Riordan et al., used ethanol to dissolve their NSAIDs which led us to
use the same technique (2011). These solutions were mixed and heated in a microwave until the
powder was completely dissolved. 10mL of each NSAID solution was extracted and then pushed
through a sterile filter to remove any impurities that may have been present.

Typical blood concentration levels of ibuprofen are between 6-10µg/mL and
acetaminophen between 10-20µg/mL. The concentration equation (𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶1 ×
𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉1 = 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶2 × 𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉𝑉2 ) was used to determine the appropriate number of
microliters needed to achieve a concentration 8µg/mL of ibuprofen and 15µg/mL of
acetaminophen. The total volume within the test tube would be 3mL. Based on the concentration
equation, it was determined that 12µL of ibuprofen and 9µL of acetaminophen should be used
through the experiment. The antibiotic used in this experiment was ampicillin. Stock solution of
ampicillin was obtained at a concentration of 10mg/mL. Again, the concentration equation was
used to calculate the amount needed to reach typical blood concentrations of both 8 and
15µg/mL. The second experiment used 2.4µL of ampicillin to achieve a concentration of
8µg/mL, and the third experiment used 4.5µL of ampicillin to achieve a concentration of
15µg/mL.
The first experiment only required E. coli, Trypticase soy broth (TSB), and NSAID stock
solutions. The decision to use TSB broth was based on a study conducted by Ileana-Andreea
Ratiu et al (2017). Researchers compared multiple broth solutions and determined that TSB is a
complex broth medium that effectively grows pathogenic bacteria, like E. coli (Ratiu et al.,
2017). 3mL of TSB and 50µL of E. coli were added to 15 test tubes and then separated into 3
sets of 5. The first set only contained E. coli and TSB. The second set received an additional
12µL of ibuprofen stock solution. And the third set received 9µL of acetaminophen stock
solution. All test tubes were placed in an incubator for 24 hours at 37°C. We chose these settings
based on an experiment designed by Noton Dutta et al., that found these parameters were optimal
for bacteria growth (2007).
The second experiment required E. coli, TSB, NSAID stock solutions, and ampicillin
(8µg/mL). 48 test tubes were separated into 3 sets of 16, with the first set containing 3mL of
TSB, 50µL of E. coli, and 2.4µL of ampicillin. The second set received an additional 12µL of
ibuprofen stock solution and the third set received an additional 9µL of acetaminophen stock
solution. All 48 test tubes were placed in an incubator for 24 hours at 37°C.
The third experiment required E. coli, TSB, NSAID stock solutions, and ampicillin
(15µg/mL). 45 test tubes were separated into 3 sets of 15, with the first set containing 3mL of
TSB, 50µL of E. coli, and 4.5µL of ampicillin. The second set received an additional 12µL of
ibuprofen stock solution and the third set received an additional 9µL of acetaminophen stock
solution. All 45 test tubes were placed in an incubator for 24 hours at 37°C.
After the incubation period, the test tubes were removed from the incubator and analyzed
using a UV-Vis spectrophotometer set at 600nm. Individually, 1mL of each test tube was
extracted and placed in a 1cm cuvette. Absorbance readings were obtained and compiled in a
Microsoft Excel spreadsheet. The average absorbance and standard deviation values were
calculated within Excel for each set within each experiment. The standard deviation of the mean
was calculated using the standard deviation divided by the square root of how many tubes were
in each set. Two t-tests were calculated, one for experiment 2 and the other for experiment 3, to
determine p-values. The t-test for experiment 2 compared ibuprofen with ampicillin (8µg/mL) to
ampicillin alone. The t-test for experiment 3 compared acetaminophen with ampicillin
(15µg/mL) to ampicillin alone.
Results/Analysis:
Experiment 1: NSAIDs and E. Coli

Figure 1. Displays the average absorbance of the bacteria (Escherichia Coli) when
acetaminophen (15µg/mL) or ibuprofen (8µg/mL) are present. Absorbance is directly
proportional to concentration, indicating higher absorbance corresponds to more bacterial
growth. Error bars represent standard deviation of mean, n=5 per column.
The first experiment determined if ibuprofen or acetaminophen had any antibacterial
properties if used independently. The average absorbance of E. coli without any treatment was
0.885 ± 0.013. When ibuprofen was added to E. coli the average absorbance was 0.804 ± 0.091.
Comparatively, acetaminophen had similar results to ibuprofen with an average absorbance of
0.807 ± 0.082. No t-test was used to establish any statistical significance due to the large overlap
of the error bars, possibly due to a small sample size. Based on figure 1, there is no evidence that
shows commonly used NSAIDs had any antibacterial properties at concentrations of 15µg/mL of
acetaminophen or 8µg/mL of ibuprofen.
Experiment 2: NSAIDs, E. Coli, Ampicillin (8µg/mL)

Figure 2. Compares the average absorbance of the bacteria (Escherichia Coli) when
acetaminophen (15µg/mL) or ibuprofen (8µg/mL) is combined with ampicillin (8ug/mL).
Absorbance is directly proportional to concentration, indicating higher absorbance corresponds
to more bacterial growth. Error bars represent standard deviation of mean, n=16 per column.
The second experiment determined whether the combination of NSAIDs and ampicillin,
at 8µg/mL, had any effect on bacterial growth. When ampicillin was used independently with E.
coli the average absorbance was 0.340 ± 0.009. However, when ibuprofen or acetaminophen is
used in conjunction with ampicillin the average absorbance values were significantly higher. The
average absorbance of ibuprofen with ampicillin was 0.723 ± 0.015. Similarly, when
acetaminophen was used with ampicillin, an average absorbance value of 0.724 ± 0.023 was
produced. Interestingly, both treatments produced similar absorbance values and had comparable
deviations. A two-sample t-test was calculated to determine the significance between ampicillin
used independently and ampicillin used with ibuprofen. The p-value was 2.91e-17, indicating
statistical significance and disproving the null hypothesis.
Experiment 3: NSAIDs, E. Coli, Ampicillin (15µg/mL)

Figure 3. Compares the average absorbance of the bacteria (Escherichia Coli) when
acetaminophen (15µg/mL) or ibuprofen (8µg/mL) is combined with ampicillin (15µg/mL).
Absorbance is directly proportional to concentration, indicating higher absorbance corresponds
to more bacterial growth. Error bars represent standard deviation of mean, n=15 per column.
The third experiment was identical to the second experiment expect for the concentration
of ampicillin (15µg/mL). A higher concentration was used because individual blood serum
concentration of ampicillin can have large variations. When ampicillin was used independently
with E. coli the average absorbance was 0.018 ± 0.004. However, when ibuprofen or
acetaminophen was used in conjunction with ampicillin the average absorbance values were
significantly higher, similarly seen in Figure 2. The average absorbance of ibuprofen with
ampicillin was 0.375 ± 0.052. Similarly, when acetaminophen was used with ampicillin, an
average absorbance value of 0.365 ± 0.061 was produced. Interestingly, both treatments
produced similar absorbance value and had comparable deviations. A two-sample t-test was
calculated to determine the significance between ampicillin used independently and ampicillin
used with acetaminophen. The p-value was 7.68e-5, indicating statistical significance and
disproving the null hypothesis.
There are multiple potential causes for the results seen in our three experiments. In a
study conducted by Agnieszka Laudy et al., they determined the activity of MDR efflux pumps
integrated within bacteria membranes (2016). The function of these pumps is to remove toxic
substances, like antibiotics, and increase bacterial survivability. Researchers also determined that
ibuprofen and acetaminophen could potentially be substrates for the efflux pump, giving them
limited or no antibacterial properties (Laudy, 2016). These findings can explain why there is no
significant difference in absorbance values when NSAIDs are used independently (Figure 1).
Another possible explanation for our results is the concept of horizontal gene transfer that
helps promote antibiotic resistance. In an experiment conducted by Yuqian Jia et al., they found
that acetaminophen specifically can increase the rate and efficiency of horizontal gene transfer
(2021). Horizontal gene transfer is a mechanism that bacteria cells use to help share DNA during
their reproduction phase (Jia et al., 2021). One common antibiotic resistant gene, MarA, is
known to participate in horizontal gene transfer making bacteria cells less susceptible to

ampicillin (Jia et al., 2021). Our results show higher absorbance values when NSAIDs are used
in combination with ampicillin at concentrations of 8µg/mL and 15µg/mL (Figure 2,3). These
results can indicate the presence of horizontal gene transfer throughout the 24hr incubation
period.
Conclusion:
The combination of NSAIDs and antibiotics are frequently used to help treat bacterial infections.
It is vital that researchers and clinicians understand any interaction that may exist between two of
the most utilized drugs. It is important to understand the limitations present within this study. We
were not able to gene sequence bacterial strains, so no conclusion can be drawn on the definite
mechanism NSAIDs use to increase the survivability of bacteria cells. It should also be noted
that other research studies incubated their bacterial cultures longer than 24hr. Future research
should include extended incubation periods as well as gene sequencing. To rule out any possible
chemical alterations between the ethanol/HCL mixture and ampicillin, additional trials can be
conducted. Future steps should include a fourth set of test tubes that contain broth, E. coli,
ethanol/HCl mixture, and ampicillin.
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